Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuromyelitis Optica | 1 | 2023 | 34 | 0.820 |
Why?
|
| Mycobacterium avium Complex | 1 | 2019 | 19 | 0.640 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2019 | 24 | 0.630 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2019 | 21 | 0.620 |
Why?
|
| Kartagener Syndrome | 1 | 2017 | 13 | 0.560 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2019 | 228 | 0.530 |
Why?
|
| Dyspnea | 1 | 2017 | 160 | 0.510 |
Why?
|
| Anemia, Sickle Cell | 1 | 2019 | 346 | 0.470 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 468 | 0.420 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 475 | 0.390 |
Why?
|
| Ribs | 1 | 2012 | 54 | 0.360 |
Why?
|
| Thoracic Injuries | 1 | 2012 | 93 | 0.360 |
Why?
|
| Pleural Effusion | 1 | 2012 | 109 | 0.350 |
Why?
|
| Asthma | 1 | 2017 | 810 | 0.320 |
Why?
|
| Fractures, Bone | 1 | 2012 | 211 | 0.310 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 239 | 0.310 |
Why?
|
| Child Abuse | 1 | 2012 | 203 | 0.300 |
Why?
|
| Neoplasms | 1 | 2023 | 3038 | 0.290 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 347 | 0.280 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2022 | 211 | 0.270 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 1979 | 0.260 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 227 | 0.170 |
Why?
|
| Physical Exertion | 1 | 2017 | 78 | 0.140 |
Why?
|
| Botulism | 1 | 2012 | 9 | 0.090 |
Why?
|
| Fibula | 1 | 2012 | 20 | 0.090 |
Why?
|
| Radius Fractures | 1 | 2012 | 22 | 0.090 |
Why?
|
| Femoral Fractures | 1 | 2012 | 34 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3857 | 0.090 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 79 | 0.090 |
Why?
|
| Multiple Trauma | 1 | 2012 | 63 | 0.090 |
Why?
|
| Pneumonia, Bacterial | 1 | 2012 | 81 | 0.090 |
Why?
|
| Child | 2 | 2023 | 25890 | 0.090 |
Why?
|
| Constipation | 1 | 2012 | 126 | 0.090 |
Why?
|
| Lung | 1 | 2017 | 1577 | 0.080 |
Why?
|
| Prognosis | 1 | 2019 | 5086 | 0.080 |
Why?
|
| Humans | 7 | 2023 | 134156 | 0.070 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2008 | 96 | 0.070 |
Why?
|
| Benzimidazoles | 1 | 2008 | 136 | 0.070 |
Why?
|
| Pyridones | 1 | 2008 | 129 | 0.070 |
Why?
|
| Sepsis | 1 | 2012 | 519 | 0.070 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2022 | 330 | 0.070 |
Why?
|
| Female | 5 | 2022 | 71928 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 2578 | 0.060 |
Why?
|
| Receptor, ErbB-2 | 1 | 2008 | 559 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 825 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2017 | 14884 | 0.050 |
Why?
|
| Birth Weight | 1 | 2022 | 354 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2022 | 257 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2022 | 5222 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2022 | 402 | 0.040 |
Why?
|
| Gestational Age | 1 | 2022 | 1229 | 0.040 |
Why?
|
| Logistic Models | 1 | 2022 | 1909 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2022 | 858 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2022 | 8623 | 0.030 |
Why?
|
| Infant | 1 | 2012 | 13240 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2008 | 4934 | 0.030 |
Why?
|
| Risk Factors | 2 | 2022 | 11182 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 178 | 0.030 |
Why?
|
| Male | 3 | 2022 | 66127 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 3416 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 3114 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17540 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7570 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 37 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2008 | 70 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2008 | 111 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2008 | 242 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 150 | 0.020 |
Why?
|
| Cell Death | 1 | 2008 | 252 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 650 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 512 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2008 | 1713 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 468 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 610 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 31945 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 2563 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 3798 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 1853 | 0.010 |
Why?
|